The effects of clozapine on the GSK-3-mediated signaling pathway

Ung Gu Kang1, Myoung Suk Seo, Myoung-Sun Roh

  • 1Department of Psychiatry and Behavioral Science, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul 110-799, South Korea.

FEBS Letters
|February 28, 2004
PubMed

Insights

Clozapine impacts glycogen synthase kinase-3beta (GSK-3beta) activity in neuroblastoma cells. It activates GSK-3beta via the Dvl-Wnt pathway, not the PI3K-Akt pathway, influencing beta-catenin levels.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Background:

  • Glycogen synthase kinase-3beta (GSK-3beta) is a key regulator in cellular signaling pathways.
  • Dysregulation of GSK-3beta is implicated in various neurological disorders.
  • Understanding drug effects on GSK-3beta is crucial for therapeutic development.

Purpose of the Study:

  • To investigate the effect of clozapine on GSK-3beta activity and associated signaling pathways.
  • To determine whether clozapine's effects are mediated through the PI3K-Akt or Wnt pathways.
  • To examine clozapine's impact on beta-catenin levels in SH-SY5Y neuroblastoma cells.

Main Methods:

  • Utilized SH-SY5Y human neuroblastoma cells.
  • Administered clozapine (10 microM) and LY294002 (20 microM, a PI3K-Akt inhibitor).
  • Assessed phosphorylation of GSK-3beta (at Ser9), Akt, and levels of beta-catenin.

Main Results:

  • Clozapine activated GSK-3beta phosphorylation at Ser9, indicating inactivation.
  • This activation was linked to both Akt- and Dvl-mediated pathways.
  • Clozapine increased total and intranuclear beta-catenin levels.
  • LY294002 inhibited Akt phosphorylation but did not affect GSK-3beta phosphorylation.

Conclusions:

  • Clozapine regulates GSK-3beta phosphorylation primarily through Wnt pathway components involving Dvl.
  • The PI3K-Akt pathway is not the primary mediator of clozapine's effect on GSK-3beta in these cells.
  • Clozapine modulates beta-catenin signaling, suggesting potential roles in neuroprotection or neurodegeneration.

Related Concept Videos

Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...